{"product_id":"mounjaro-trizepatida-pluma-precargada-kwikpen-de-10mg-0-6ml-con-1","title":"Mounjaro (Tirzepatide) 10mg\/0.6ml Kwikpen Prefilled Pen With 1","description":"\u003ch2\u003eCategory\u003c\/h2\u003e\n\u003cp\u003eMedications\u003c\/p\u003e\n\n\u003ch2\u003eLine\u003c\/h2\u003e\n\u003cp\u003eAntidiabetics\u003c\/p\u003e\n\n\u003ch2\u003eBrand\u003c\/h2\u003e\n\u003cp\u003eMounjaro\u003c\/p\u003e\n\n\u003ch2\u003eMolecule\u003c\/h2\u003e\n\u003cp\u003eTirzepatide\u003c\/p\u003e\n\n\u003ch2\u003ePresentation\u003c\/h2\u003e\n\u003cp\u003e10 mg\/0.6 ml Kwikpen Pre-filled Pen\u003c\/p\u003e\n\n\u003ch2\u003eLaboratory\u003c\/h2\u003e\n\u003cp\u003eLilly\u003c\/p\u003e\n\n\u003ch2\u003eIndications\u003c\/h2\u003e\n\u003cp\u003eMounjaro (Tirzepatide) is indicated as a treatment for type 2 diabetes in adults. This medication acts as a dual GLP-1 and GIP receptor agonist, which helps improve glycemic control by stimulating glucose-dependent insulin secretion, decreasing glucagon secretion, and delaying gastric emptying. Its use is recommended in combination with an appropriate diet and exercise to achieve optimal blood glucose control. Additionally, Mounjaro has been observed to contribute to weight reduction in overweight or obese patients, which is beneficial for the comprehensive management of type 2 diabetes.\u003c\/p\u003e\n\n\u003ch2\u003eComposition\u003c\/h2\u003e\n\u003cp\u003eEach Mounjaro pre-filled pen contains 10 mg of Tirzepatide per 0.6 ml of injectable solution.\u003c\/p\u003e\n\n\u003ch2\u003eContraindications\u003c\/h2\u003e\n\u003cp\u003eThis medication is contraindicated in patients with a history of pancreatitis or pancreatic disease, as well as in those with hypersensitivity to tirzepatide or any of the excipients. Its use is not recommended in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis.\u003c\/p\u003e\n\n\u003ch2\u003ePrecautions\u003c\/h2\u003e\n\u003cp\u003eCaution should be exercised when administering Mounjaro in patients with a history of gastrointestinal disease, as it may cause adverse effects such as nausea and vomiting. Additionally, renal function should be assessed before starting treatment, as impaired renal function may affect drug metabolism. It is important to monitor blood glucose to avoid episodes of hypoglycemia, especially in patients receiving other antidiabetic medications.\u003c\/p\u003e\n\n\u003ch2\u003eStorage\u003c\/h2\u003e\n\u003cp\u003eStore in a refrigerator between 2 °C and 8 °C. Do not freeze. Keep out of reach of children.\u003c\/p\u003e\n\n\u003cp\u003ePrescription required.\u003c\/p\u003e\n\u003cp\u003eConsult your doctor.\u003c\/p\u003e","brand":"Lilly","offers":[{"title":"Default Title","offer_id":48257389494497,"sku":"7501082243741","price":10500.3,"currency_code":"MXN","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0722\/1500\/3361\/files\/mounjaro_trizepatida_pluma_precargada_kwikpen_de_10mg_0_6ml_con_1_7501082243741_1.jpg?v=1779153400","url":"https:\/\/wecarepharma.mx\/en\/products\/mounjaro-trizepatida-pluma-precargada-kwikpen-de-10mg-0-6ml-con-1","provider":"WeCare Pharma","version":"1.0","type":"link"}